Analysis Continuous manufacturing builds on hype but adoption remains gradual Brexit, Covid-19, and a drive for sustainability has bumped the move towards continuous manufacturing, even though large-scale investment drags By Adam Zamecnik
Comment Supply chain report: make CMO agreements public, but ‘glib’ onshoring not the answer By Fiona Barry
Insulin pricing: could an e-commerce approach cut costs? An e-commerce drug delivery approach could put a dent in upward spiraling insulin prices, but uptake challenges loom large. а> By William Newton
Analysis Two years of Covid-19: lessons the pandemic taught about delivering essential vaccines By Darcy Jimenez
Analysis Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compared to the West By Adam Zamecnik
Analysis Bluebird bio’s gene therapy Zynteglo could have high price tag defense in beta thalassemia By Adam Zamecnik
Ukraine Crisis Russia sanctions: what next for Sputnik Covid-19 vaccine production around the world? By Manasi Vaidya and Fiona Barry
Comment Advancements in GA pipeline brings first wave of therapies closer to patients By GlobalData Healthcare
Comment Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments By GlobalData Healthcare
Comment Entrance of novel therapies drives alpha-1 antitrypsin deficiency market growth By GlobalData Healthcare
Comment FDA’s complete response letter may cost HUTCHMED nearly $100m in potential sales By GlobalData Healthcare
Comment Tislelizumab makes headway towards approval in ESCC but faces tough competition By GlobalData Healthcare
AI innovation among pharma companies has dropped off in the last year J&J was the top AI innovator in pharma in the latest quarter. The company filed 48 AI related patents in… а> By Data Journalism Team
Filings Pharma filings buzz with cybersecurity mentions with a 48% increase in Q3 2021 By Data Journalism Team
Jobs North America is seeing a hiring boom in pharmaceutical industry ESG roles By Data Journalism Team
Analysis Robotics-related deals in the pharmaceutical industry increased in H1 2021 By Saywah Mahmood
South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape 1995
Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape 1995
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape 3495
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape 3495